RAD001 and Bicalutamide for Androgen Independent Prostate Cancer

Clinical trial NCT00630344 · COMPLETED

Trial details

NCT number: NCT00630344
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2008-02-01
Primary completion: 2012-05-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.